mt-102
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2011 (NCT01238107)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mt-102
- mt-102
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01238107 | Phase 2 | Apr 1, 2011 | PsiOxus Therapeutics Ltd, Tata Memorial Hospital, Veeda Clinical Research |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PsiOxus Therapeutics Ltd | For profit | 1 | 1 | 1 | 2011 |
| Tata Memorial Hospital | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Veeda Clinical Research | For profit | 1 | 0 | 1 | 2011 |
3 organizations
Page 1 / 1